Home > Publications database > Genome-wide interaction study with smoking for colorectal cancer risk identifies novel genetic loci related to tumor suppression, inflammation and immune response. > print

001     186491
005     20240229145749.0
024 7 _ |a 10.1158/1055-9965.EPI-22-0763
|2 doi
024 7 _ |a pmid:36576985
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:140636488
|2 altmetric
037 _ _ |a DKFZ-2022-03212
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Carreras-Torres, Robert
|0 0000-0002-2925-734X
|b 0
245 _ _ |a Genome-wide interaction study with smoking for colorectal cancer risk identifies novel genetic loci related to tumor suppression, inflammation and immune response.
260 _ _ |a Philadelphia, Pa.
|c 2023
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1678881891_29492
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Mar 6;32(3):315-328
520 _ _ |a Tobacco smoking is an established risk factor for colorectal cancer (CRC). However, genetically-defined population subgroups may have increased susceptibility to smoking-related effects on CRC.A genome-wide interaction scan was performed including 33,756 CRC cases and 44,346 controls from three genetic consortia.Evidence of an interaction was observed between smoking status (ever vs never smokers) and a locus on 3p12.1 (rs9880919, p=4.58x10-8), with higher associated risk in subjects carrying the GG genotype (OR 1.25, 95%CI 1.20-1.30) compared with the other genotypes (OR <1.17 for GA and AA). Among ever smokers, we observed interactions between smoking intensity (increase in 10 cigarettes smoked per day) and two loci on 6p21.33 (rs4151657, p=1.72x10-8) and 8q24.23 (rs7005722, p=2.88x10-8). Subjects carrying the rs4151657 TT genotype showed higher risk (OR 1.12, 95%CI 1.09-1.16) compared with the other genotypes (OR <1.06 for TC and CC). Similarly, higher risk was observed among subjects carrying the rs7005722 AA genotype (OR 1.17, 95%CI 1.07-1.28) compared with the other genotypes (OR <1.13 for AC and CC). Functional annotation revealed that SNPs in 3p12.1 and 6p21.33 loci were located in regulatory regions, and were associated with expression levels of nearby genes. Genetic models predicting gene expression revealed that smoking parameters were associated with lower CRC risk with higher expression levels of CADM2 (3p12.1) and ATF6B (6p21.33).Our study identified novel genetic loci that may modulate the risk for CRC of smoking status and intensity, linked to tumor suppression and immune response.These findings can guide potential prevention treatments.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Kim, Andre E
|0 0000-0003-1217-5249
|b 1
700 1 _ |a Lin, Yi
|0 0000-0001-8644-614X
|b 2
700 1 _ |a Díez-Obrero, Virginia
|0 0000-0002-0163-9872
|b 3
700 1 _ |a Bien, Stephanie A
|0 0000-0002-8713-4583
|b 4
700 1 _ |a Qu, Conghui
|0 0000-0003-1927-6245
|b 5
700 1 _ |a Wang, Jun
|0 0000-0001-8372-1863
|b 6
700 1 _ |a Dimou, Niki
|0 0000-0003-1678-9328
|b 7
700 1 _ |a Aglago, Elom Kouassivi
|0 0000-0002-0442-3284
|b 8
700 1 _ |a Albanes, Demetrius
|0 0000-0001-8330-4293
|b 9
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 10
|u dkfz
700 1 _ |a Baurley, James W
|0 0000-0003-4116-7723
|b 11
700 1 _ |a Berndt, Sonja I
|0 0000-0001-5230-0652
|b 12
700 1 _ |a Bézieau, Stéphane
|0 0000-0003-0095-1319
|b 13
700 1 _ |a Bishop, D Timothy
|0 0000-0002-8752-8785
|b 14
700 1 _ |a Bouras, Emmanouil
|0 0000-0003-1489-5506
|b 15
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 16
|u dkfz
700 1 _ |a Budiarto, Arif
|0 0000-0001-8875-6694
|b 17
700 1 _ |a Campbell, Peter T
|0 0000-0002-5549-2036
|b 18
700 1 _ |a Casey, Graham
|0 0000-0003-1584-5551
|b 19
700 1 _ |a Chan, Andrew T
|0 0000-0001-7284-6767
|b 20
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 21
|u dkfz
700 1 _ |a Chen, Xuechen
|0 P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9
|b 22
|u dkfz
700 1 _ |a Conti, David V
|0 0000-0002-2941-7833
|b 23
700 1 _ |a Dampier, Christopher H
|0 0000-0003-3099-6462
|b 24
700 1 _ |a Devall, Matthew Am
|0 0000-0001-5943-4397
|b 25
700 1 _ |a Drew, David A
|0 0000-0002-8813-0816
|b 26
700 1 _ |a Figueiredo, Jane C
|0 0000-0001-8040-3341
|b 27
700 1 _ |a Gallinger, Steven
|0 0000-0002-6998-9414
|b 28
700 1 _ |a Giles, Graham G
|0 0000-0003-4946-9099
|b 29
700 1 _ |a Gruber, Stephen B
|0 0000-0001-8656-7822
|b 30
700 1 _ |a Gsur, Andrea
|0 0000-0002-9795-1528
|b 31
700 1 _ |a Gunter, Marc J
|0 0000-0001-5472-6761
|b 32
700 1 _ |a Harrison, Tabitha A
|0 0000-0002-4173-7530
|b 33
700 1 _ |a Hidaka, Akihisa
|0 0000-0002-1772-8159
|b 34
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 35
|u dkfz
700 1 _ |a Huyghe, Jeroen R
|0 0000-0001-6027-9806
|b 36
700 1 _ |a Jenkins, Mark A
|0 0000-0002-8964-6160
|b 37
700 1 _ |a Jordahl, Kristina M
|0 0000-0001-5165-5769
|b 38
700 1 _ |a Kawaguchi, Eric
|0 0000-0003-2014-5023
|b 39
700 1 _ |a Keku, Temitope O
|0 0000-0003-4019-3903
|b 40
700 1 _ |a Kundaje, Anshul
|0 0000-0003-3084-2287
|b 41
700 1 _ |a Le Marchand, Loic
|0 0000-0001-5013-980X
|b 42
700 1 _ |a Lewinger, Juan Pablo
|0 0000-0002-0692-2570
|b 43
700 1 _ |a Li, Li
|b 44
700 1 _ |a Mahesworo, Bharuno
|0 0000-0003-1017-2917
|b 45
700 1 _ |a Morrison, John L
|0 0000-0003-1478-9965
|b 46
700 1 _ |a Murphy, Neil
|0 0000-0003-3347-8249
|b 47
700 1 _ |a Nan, Hongmei
|0 0000-0002-9957-616X
|b 48
700 1 _ |a Nassir, Rami
|0 0000-0001-9914-7851
|b 49
700 1 _ |a Newcomb, Polly A
|0 0000-0001-8786-0043
|b 50
700 1 _ |a Obón-Santacana, Mireia
|0 0000-0003-4646-3513
|b 51
700 1 _ |a Ogino, Shuji
|0 0000-0002-3909-2323
|b 52
700 1 _ |a Ose, Jennifer
|b 53
700 1 _ |a Pai, Rish K
|0 0000-0002-2692-221X
|b 54
700 1 _ |a Palmer, Julie R
|0 0000-0002-6534-335X
|b 55
700 1 _ |a Papadimitriou, Nikos
|0 0000-0001-8294-7262
|b 56
700 1 _ |a Pardamean, Bens
|0 0000-0002-7404-9005
|b 57
700 1 _ |a Peoples, Anita R
|0 0000-0003-3645-3960
|b 58
700 1 _ |a Pharoah, Paul D P
|0 0000-0001-8494-732X
|b 59
700 1 _ |a Platz, Elizabeth A
|0 0000-0003-3676-8954
|b 60
700 1 _ |a Rennert, Gad
|0 0000-0002-8512-068X
|b 61
700 1 _ |a Ruiz-Narvaez, Edward
|0 0000-0002-0339-5824
|b 62
700 1 _ |a Sakoda, Lori C
|0 0000-0002-0900-5735
|b 63
700 1 _ |a Scacheri, Peter C
|0 0000-0002-7629-918X
|b 64
700 1 _ |a Schmit, Stephanie L
|0 0000-0001-5931-1194
|b 65
700 1 _ |a Schoen, Robert E
|0 0000-0001-7153-2766
|b 66
700 1 _ |a Shcherbina, Anna
|0 0000-0002-5080-5494
|b 67
700 1 _ |a Slattery, Martha L
|0 0000-0002-1655-6543
|b 68
700 1 _ |a Stern, Mariana C
|0 0000-0001-9777-4683
|b 69
700 1 _ |a Su, Yu-Ru
|0 0000-0001-6150-960X
|b 70
700 1 _ |a Tangen, Catherine M
|0 0000-0001-8825-8660
|b 71
700 1 _ |a Thomas, Duncan C
|0 0000-0002-6040-8804
|b 72
700 1 _ |a Tian, Yu
|b 73
700 1 _ |a Tsilidis, Konstantinos K
|0 0000-0002-8452-8472
|b 74
700 1 _ |a Ulrich, Cornelia M
|0 0000-0001-7641-059X
|b 75
700 1 _ |a van Duijnhoven, Fränzel J B
|0 0000-0001-8367-2352
|b 76
700 1 _ |a Van Guelpen, Bethany
|0 0000-0002-9692-101X
|b 77
700 1 _ |a Visvanathan, Kala
|0 0000-0002-0582-8005
|b 78
700 1 _ |a Vodicka, Pavel
|0 0000-0003-2376-1243
|b 79
700 1 _ |a Cenggoro, Tjeng Wawan
|0 0000-0002-9872-9646
|b 80
700 1 _ |a Weinstein, Stephanie J
|0 0000-0002-3834-1535
|b 81
700 1 _ |a White, Emily
|0 0000-0003-0544-1633
|b 82
700 1 _ |a Wolk, Alicja
|0 0000-0001-7387-6845
|b 83
700 1 _ |a Woods, Michael O
|0 0000-0001-8180-418X
|b 84
700 1 _ |a Hsu, Li
|0 0000-0001-8168-4712
|b 85
700 1 _ |a Peters, Ulrike
|0 0000-0001-5666-9318
|b 86
700 1 _ |a Moreno, Victor
|0 0000-0002-2818-5487
|b 87
700 1 _ |a Gauderman, W James
|0 0000-0002-6626-9091
|b 88
773 _ _ |a 10.1158/1055-9965.EPI-22-0763
|g p. EPI-22-0763
|0 PERI:(DE-600)2036781-8
|n 3
|p 315-328
|t Cancer epidemiology, biomarkers & prevention
|v 32
|y 2023
|x 1055-9965
909 C O |p VDB
|o oai:inrepo02.dkfz.de:186491
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2022
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-19
920 1 _ |0 I:(DE-He78)C071-20160331
|k C071
|l C071 Cancer Survivorship
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C071-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21